Literature DB >> 31663787

Selecting dopamine depleters for hyperkinetic movement disorders: how do we choose?

Laszlo Szpisjak1, Andras Salamon1, Denes Zadori1, Peter Klivenyi1, Laszlo Vecsei1,2,3.   

Abstract

Entities:  

Keywords:  Deutetrabenazine; VMAT2 inhibitor; hyperkinetic; movement disorders; tetrabenazine; valbenazine

Year:  2019        PMID: 31663787     DOI: 10.1080/14656566.2019.1685980

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  1 in total

Review 1.  A Brief Review on the Role of Vesicular Monoamine Transporter2 Inhibitors in Hyperkinetic Movement Disorders.

Authors:  Ali Nikkhah
Journal:  Iran J Child Neurol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.